Kathryn R. Coser - Concepedia

Concepedia

Author

Kathryn R. Coser

Massachusetts General Hospital ORCID

Also Known As

K.R. Coser, Kathryn Coser, Kathryn R. Coser

25

Publications

1.3K

Citations

19

H-Index

65

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Center for Cancer Research Centers for New Horizons Boston Children's Hospital

KR

About

Kathryn R. Coser is an author at Massachusetts General Hospital specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	592
2	Cell Biology	9	9	458
3	Public Health	3	3	82
4	Natural Sciences	1	1	25
5	Biostatistics	1	1	28

Kathryn R. Coser

×

20

Publications

1.3K

Citations

19

H-Index

	Year	Citations
Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray Kathryn R. Coser, Jessica Chesnes, Jingyung Hur, Proceedings of the National Academy of Sciences	2003	243
Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein Tetsuro Yahata, Wenlin Shao, Hideki Endoh, Genes & Development	2001	134
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension Ivana Nikolić, Lai‐Ming Yung, Peiran Yang, American Journal of Respiratory and Critical Care Medicine	2018	107
The Prognostic Biomarkers <i>HOXB13, IL17BR</i>, and <i>CHDH</i> Are Regulated by Estrogen in Breast Cancer Zuncai Wang, Sonika Dahiya, Heather L. Provencher, Clinical Cancer Research	2007	97
The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis Jingyung Hur, Jessica Chesnes, Kathryn R. Coser, Proceedings of the National Academy of Sciences	2004	78
HD CAG-correlated gene expression changes support a simple dominant gain of function Jessie C. Jacobsen, Gillian Gregory, Juliana Woda, Human Molecular Genetics GeneticsGenomic MechanismGene Regulatory NetworkEpigeneticsCag Size	2011	75
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase Wei‐Lan Yeh, Keiko Shioda, Kathryn R. Coser, PLoS ONE Breast OncologyImmunologyCell DeathFulvestrant-induced Cell DeathCancer Biology	2013	74
Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor Kathryn R. Coser, Ben S. Wittner, Noël F. Rosenthal, Proceedings of the National Academy of Sciences Tumor BiologyBreast Cancer ResistanceBreast OncologyMedicinePharmacology	2009	69
Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens Toshi Shioda, Jessica Chesnes, Kathryn R. Coser, Proceedings of the National Academy of Sciences Breast OncologyGeneticsOvarian CancerDosage StandardizationDosage Criteria	2006	65
Regulation of Expression of BIK Proapoptotic Protein in Human Breast Cancer Cells: p53-Dependent Induction of BIK mRNA by Fulvestrant and Proteasomal Degradation of BIK Protein Jingyung Hur, Daphne W. Bell, Kathleen L. Dean, Cancer Research ApoptosisCell DeathTumor BiologyTranscriptional RegulationCell Regulation	2006	59

Page 1